Dopamine d2 Receptor Antikörper (AA 194-421)
Kurzübersicht für Dopamine d2 Receptor Antikörper (AA 194-421) (ABIN7616221)
Target
Alle Dopamine d2 Receptor (DRD2) Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 194-421
-
Verwendungszweck
- Dopamine Receptor D2 (DRD2) Polyclonal Antibody
-
Sequenz
- Ser194~Ala421
-
Produktmerkmale
- The Dopamine Receptor D2 (DRD2) Polyclonal Antibody (Species: Mouse) has been validated for the following applications: WB, IHC, ICC, IP.
-
Aufreinigung
- Antigen-specific affinity chromatography followed by Protein A affinity chromatography
-
-
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 1 mg/mL
-
Buffer
- PBS, pH 7.4, containing 0.02 % Sodium azide, 50 % glycerol
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- 4 °C,-20 °C
-
Informationen zur Lagerung
- 2°C to 8°C for frequent use, -20°C for 12 months. Avoid repeated freeze/thaw cycles.
-
Haltbarkeit
- 12 months
-
-
- Dopamine d2 Receptor (DRD2) (Dopamine Receptor D2 (DRD2))
-
Andere Bezeichnung
- DRD2
-
Gen-ID
- 13489
-
UniProt
- P61168
-
Pathways
- Positive Regulation of Peptide Hormone Secretion, Negative Regulation of Hormone Secretion, cAMP Metabolic Process, Inositol Metabolic Process, Regulation of G-Protein Coupled Receptor Protein Signaling, Feeding Behaviour, Negative Regulation of Transporter Activity, Regulation of long-term Neuronal Synaptic Plasticity
Target
-